Toll Free: 1-888-928-9744
Published: Sep, 2014 | Pages:
90 | Publisher: Netscribes
Industry: Healthcare | Report Format: Electronic (PDF)
Netscribes' latest market research report titled Oncology Pharmaceutical Market in India 2014 highlights the analysis of the drivers and explains the factors for growth of the industry. Increasing number of cancer cases are the key drivers of this market. Lung, stomach, colon and breast cancer cause the maximum number of cancer deaths each year. Pharmaceutical companies are progressively increasing R&D expenditure on cancer vaccines. The growing number of patients seeking treatment for cancer has made hospitals realize that cancer treatment is an important area for growth. Gleevec, Mabthera, Iressa, Avastin, Grafeel, Soliris and Herceptin are the top selling cancer drugs in the Indian market. Alternative therapies such as cancer gene therapy and cancer cell therapy are increasingly becoming popular in cases where conventional therapies have failed. Combination therapies are being increasingly used in cancer treatments. Some challenges faced by the industry are the internal competition between large pharmaceutical companies. Another challenge is the penetration of Oncological drugs in rural areas which is very low. Various government initiatives have been undertaken to reduce the drug prices and various tax reforms and control programs are promoting the growth of the market as well. Manufacture of generic oncology drugs will help the pharmaceutical manufacturer gain a competitive advantage over others in a highly competitive pharma market. Companies should focus on development of new molecules in order to prolong the longevity of a blockbuster drug in the market.
Table of Contents
Slide 1: Executive Summary Macroeconomic Indicators Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013) Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Oct 2013 - Mar 2014) Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13) Introduction Slide 5-6: Types of Chemotherapy drugs Market Overview Slide 7-9: Global Oncology Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e), Indian Oncology Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e), Regions with high cancer prevalence, Top 5 cancer's in India Export-Import Slide 10-11: Region wise Exports, Total Exports, Region wise Imports, Total Imports Value Chain Slide 12-13: Market Value Chain Analysis Drivers & Challenges Slide 14: Drivers and Challenges - Summary Slide 15-19: Drivers Slide 20-22: Challenges Government Initiatives Slide 23: Government Initiatives - Summary Slide 24: Helping the Market to grow Slide 25: National List of Essential Medicines (NLEM), Jan Aushadhi Stores (JAS) Slide 26-27: cancer awareness programmes Slide 28: Reduction in Excise Duties Regulations Slide 29: Licensing and registration of pharmaceuticals Slide 30: Various other regulatory frameworks Slide 31-33: Patent Approvals Competitive Landscape Slide 34: Porter's Five Forces Analysis Slide 35: Public Trading Comparables, Top 3 Companies Slide 36-38: Competitive Benchmarking, Key Ratios of Top 3 Companies - Operational Basis (FY 2013) Slide 39: Competitive Benchmarking, Key Ratios of Top 3 Companies - Financial Basis (FY 2013) Slide 40-75: Major Public Players Slide 76-85: major Private Players Recent Developments Slide 86-87: Recent Developments Strategic Recommendation Slide 88: Strategic recommendation Appendix Slide 89: Key Ratios Description Slide 90: Sources of Information
List of Tables
Market Overview 1. Top 5 Cancer Drugs (Based on Sales-2012) 2. Top 5 cancer in India Regulation & Patents 1. Patent Approvals Competitive Landscape 1. Public Trading Comparables 2. Company Profiles (All Companies) a. Company Information (All Companies) b. Products and Services (All Companies) c. Key People (All Companies) d. Key Financial Performance Indicators (All Companies) e. Key Ratios (All Companies) f. Business Highlights (All Companies) Recent Developments 1. Recent developments Appendix 1. Key Ratios Description 2. Sources of Information
Our library has over 100000 reports on 1000s of topics
Over 100+ Fortune 500 companies rely on us
90,000+ people come to us for insights every month
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.